Vedanta Biosciences

Showing 2 posts of 2 posts found.

Pfizer invests $25m in Vedanta BioSciences’ IBD treatment

January 13, 2021
Research and Development Pfizer, Vedanta Biosciences, inflammatory bowel disease

Pfizer has invested $25 million in Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases, …

bruce_roberts_vedanta

PureTech’s Vedanta Biosciences appoints former Genzyme VP chief scientific officer

March 16, 2016
Medical Communications, Research and Development Bruce Roberts, Genzyme, Vedanta Biosciences

Vedanta Biosciences, a company developing therapies designed to modulate the human microbiome, has appointed former Genzyme group vice president, Bruce …

The Gateway to Local Adoption Series

Latest content